Pharma Marketing Network

JULY 27, 2022

Sunny White is an editorial advisory board member for the Pharma Marketing Network with hands-on experience helping pharmaceutical marketers elevate their promotional material to meet the unique needs of patients and caregivers while remaining compliant. The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products.

Patients 130

Patients Education Retail Pharma 130

European Pharmaceutical Review

DECEMBER 14, 2023

Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. But from a safety point of view, observational studies can be more representative of the population the drug will serve. Meta-analyses contributed least frequently (31.4

Safety 108

Safety Medicine Competition Networking 108

PharmaKinnex

AUGUST 23, 2022

More convenience and safety? Fewer Networking & Industry Trade Show Events. As the pandemic ramped up, patients and prescribers ditched their traditional methods of interacting within the office and telemedicine became the new norm. What’s not to love? Higher Travel & Marketing Costs.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

European Pharmaceutical Review

FEBRUARY 14, 2023

Robust analytical methods are needed to establish safety, potency, and purity of mRNA therapeutics in large-scale manufacturing. Sarah Bundra, Pharmaceutical Analyst at GlobalData also warned about patient safety: “introducing mRNA carries the risk of activating the immune system.”

Food and Drug Administration 84

Food and Drug Administration Medicine Safety Consulting 84

European Pharmaceutical Review

SEPTEMBER 22, 2023

7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.

Food and Drug Administration 71

Food and Drug Administration Safety Patients Leads 71

PM360

JULY 13, 2023

However, due to conjugation instability and unfavorable safety profiles of currently available ADCs, we can still do more to ensure ADCs are more broadly available and amenable options for the patients who need them. Preliminary data are expected in 2023.

Patients 98

Patients Engineering Side effects Leads 98

Evolve Your Success

MAY 30, 2023

What’s happening where companies in healthcare do a great job is product training and on training their teams to communicate the clinical safety and efficacy aspects of their technology. That changed into a big change management effort I worked on when Johnson & Johnson tried to buy the company back in like 2002. That didn’t work.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52